Published in CMAJ on June 07, 2005
Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev (2009) 1.17
Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12. Am J Clin Nutr (2011) 1.08
Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine. Nephrol Dial Transplant (2015) 0.91
Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke (2013) 0.83
Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity. Cardiovasc J Afr (2013) 0.78
Vitamin B12 and homocysteine. CMAJ (2005) 0.77
Blood Concentrations of Homocysteine and Methylmalonic Acid among Demented and Non-Demented Swedish Elderly with and without Home Care Services and Vitamin B(12) Prescriptions. Dement Geriatr Cogn Dis Extra (2012) 0.75
Vitamin B12 and homocysteine. CMAJ (2005) 0.75
Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia. Mol Cell Biochem (2017) 0.75
Carotid plaque burden is associated with higher levels of total homocysteine. Stroke Vasc Neurol (2017) 0.75
Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med (1997) 5.35
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med (2001) 5.09
Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA (1997) 3.87
Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08
Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med (2004) 2.75
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem (1994) 2.14
Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke (2002) 2.10
Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet (1995) 1.79
Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism (1993) 1.62
Vitamin Intervention for Stroke Prevention (VISP) trial: rationale and design. Neuroepidemiology (2001) 1.21
Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr (2003) 1.13
The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr (1996) 1.07
Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk (1998) 1.04
Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification. Public Health Rev (2000) 0.96
Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc (2002) 0.96
Effect of folic acid fortification of food on homocysteine-related mortality. Am J Med (2004) 0.91
The prevention of congenital anomalies with periconceptional folic acid supplementation. J Obstet Gynaecol Can (2003) 0.89
Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5 mg daily. Am J Nephrol (1999) 0.84
Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial. Am J Kidney Dis (2004) 0.80
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA (2010) 4.05
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord (2009) 3.56
Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke (2007) 2.63
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Median nerve superficial to the transverse carpal ligament. Orthopedics (2015) 1.97
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Sex and menopausal status influence human dietary requirements for the nutrient choline. Am J Clin Nutr (2007) 1.76
Cytoplasmic serine hydroxymethyltransferase regulates the metabolic partitioning of methylenetetrahydrofolate but is not essential in mice. J Biol Chem (2008) 1.73
Motor vehicle accidents: the most common cause of traumatic vertebrobasilar ischemia. Can J Neurol Sci (2003) 1.56
Geometry of the carotid bifurcation predicts its exposure to disturbed flow. Stroke (2008) 1.54
Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. Am J Clin Nutr (2011) 1.53
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy. Mol Cancer Ther (2002) 1.51
Influence of noninvasive cardiovascular imaging in primary prevention: systematic review and meta-analysis of randomized trials. Arch Intern Med (2011) 1.50
Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr (2004) 1.46
Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors. Diabetes Care (2005) 1.46
Diabetes, intracranial stenosis and microemboli in asymptomatic carotid stenosis. Can J Neurol Sci (2013) 1.41
Comparing McRoberts' and Rubin's maneuvers for initial management of shoulder dystocia: an objective evaluation. Am J Obstet Gynecol (2005) 1.40
Episiotomy versus fetal manipulation in managing severe shoulder dystocia: a comparison of outcomes. Am J Obstet Gynecol (2004) 1.39
Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fluid dynamics and MRI. Magn Reson Med (2002) 1.38
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol (2012) 1.34
Extremes of unexplained variation as a phenotype: an efficient approach for genome-wide association studies of cardiovascular disease. Circ Cardiovasc Genet (2010) 1.33
Methyl balance and transmethylation fluxes in humans. Am J Clin Nutr (2007) 1.33
S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A (2004) 1.32
High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations. Hum Mutat (2002) 1.29
Zinc, gravida, infection, and iron, but not vitamin B-12 or folate status, predict hemoglobin during pregnancy in Southern Ethiopia. J Nutr (2008) 1.29
Dietary intervention to reverse carotid atherosclerosis. Circulation (2010) 1.28
New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation (2011) 1.27
Variation in the carotid bifurcation geometry of young versus older adults: implications for geometric risk of atherosclerosis. Stroke (2005) 1.27
Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke (2004) 1.26
Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke (2004) 1.21
Quantification of serum and urinary S-adenosylmethionine and S-adenosylhomocysteine by stable-isotope-dilution liquid chromatography-mass spectrometry. Clin Chem (2003) 1.20
Sex differences in carotid plaque and stenosis. Stroke (2004) 1.20
Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension (2007) 1.19
3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. Stroke (2005) 1.17
Maternal choline intake modulates maternal and fetal biomarkers of choline metabolism in humans. Am J Clin Nutr (2012) 1.17
Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J (2008) 1.17
Identification and quantitation of cobalamin and cobalamin analogues in human feces. Am J Clin Nutr (2008) 1.16
Mthfd1 is an essential gene in mice and alters biomarkers of impaired one-carbon metabolism. J Biol Chem (2008) 1.14
Versatility in corrinoid salvaging and remodeling pathways supports corrinoid-dependent metabolism in Dehalococcoides mccartyi. Appl Environ Microbiol (2012) 1.14
Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis (2005) 1.13
Screening for cobalamin deficiency in geriatric outpatients: prevalence and influence of synthetic cobalamin intake. J Am Geriatr Soc (2002) 1.09
Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency. Metabolism (2002) 1.08
Treatment of renal artery stenosis. JAMA (2013) 1.08
Ultrasonographic measure of carotid plaque burden. JACC Cardiovasc Imaging (2013) 1.07
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol (2009) 1.05
Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency. Mol Genet Metab (2007) 1.04
Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS One (2011) 1.03
Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment. Mol Genet Metab (2010) 1.03
Vitamin B12 deficiency. N Engl J Med (2013) 1.03
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes. Cardiovasc Ultrasound (2005) 1.02
MTHFR C677T genotype influences the isotopic enrichment of one-carbon metabolites in folate-compromised men consuming d9-choline. Am J Clin Nutr (2010) 1.01
Adverse event associated with methionine loading test: a case report. Arterioscler Thromb Vasc Biol (2002) 1.01
Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc nutrition services. Am J Clin Nutr (2003) 1.01
A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment. Mol Genet Metab (2010) 1.00
Cystathionine protects against endoplasmic reticulum stress-induced lipid accumulation, tissue injury, and apoptotic cell death. J Biol Chem (2012) 1.00
Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease. J Hepatol (2010) 0.99
Nuclear localization of de novo thymidylate biosynthesis pathway is required to prevent uracil accumulation in DNA. J Biol Chem (2011) 0.99
Low ratio of S-adenosylmethionine to S-adenosylhomocysteine is associated with vitamin deficiency in Brazilian pregnant women and newborns. Am J Clin Nutr (2004) 0.98
Progression of carotid plaque volume predicts cardiovascular events. Stroke (2013) 0.98
Antihypertensive treatment can prevent stroke and cognitive decline. Nat Rev Neurol (2012) 0.97
Asymptomatic carotid stenosis: mainly a medical condition. Vascular (2010) 0.97
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency. Am J Med Genet (2002) 0.97
Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults. J Am Geriatr Soc (2002) 0.96
Carotid stenosis. N Engl J Med (2013) 0.95
Immune profiling of Alzheimer patients. J Neuroimmunol (2011) 0.94
S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial. Alcohol Clin Exp Res (2011) 0.94
Mechanisms of lipoprotein(a) pathogenicity: prothrombotic, proatherosclerotic, or both? Arterioscler Thromb Vasc Biol (2012) 0.94
Enzymatic activity of methionine adenosyltransferase variants identified in patients with persistent hypermethioninemia. Mol Genet Metab (2010) 0.94
Prioritizing posterior arm delivery during severe shoulder dystocia. Obstet Gynecol (2003) 0.93
Cystathionine gamma-lyase: Clinical, metabolic, genetic, and structural studies. Mol Genet Metab (2009) 0.93
Infantile hypermethioninemia and hyperhomocysteinemia due to high methionine intake: a diagnostic trap. Mol Genet Metab (2003) 0.92
Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 0.92